Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesDigital X-RayBone-RADS improves accuracy for junior, attending physicansACR's Bone-RADS led to improved diagnostic accuracy for junior and attending physicians, but lower accuracy for senior physicians.MRIMRI, CT, ultrasound biomarkers help identify Crohn disease stricturesWomens ImagingLow breast cancer screening prevalence tied to socioeconomic factorsMolecular ImagingPET/CT reveals ‘chemo brain’ regions in leukemia patientsAIStanford AIDE lab proposes radiology AI safety monitoring model